Health Sciences Acquisitions Corp 2
Completed 2023-01-25- CIK 1814114
- HSAQ
- Now OBIO
- IPO 2020-08-05
- $67.8M trust
- 408 filings
Successfully merged with Orchestra BioMed, Inc. • Now trading as OBIO
- IPO Size
- $160M
- raised at the IPO
- Trust
- $67.8M
- as of 2022-12-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
408 filings over 27 quarters; violet bars carry a milestone
- 20 Q2: 1 filing
- 20 Q3: 28 filings
- 20 Q4: 1 filing
- 21 Q1: 2 filings
- 21 Q2: 1 filing
- 21 Q3: 1 filing
- 21 Q4: 1 filing
- 22 Q1: 4 filings
- 22 Q2: 5 filings
- 22 Q3: 18 filings
- 22 Q4: 25 filings
- 23 Q1: 40 filings
- 23 Q2: 35 filings
- 23 Q3: 19 filings
- 23 Q4: 6 filings
- 24 Q1: 12 filings
- 24 Q2: 33 filings
- 24 Q3: 24 filings
- 24 Q4: 9 filings
- 25 Q1: 10 filings
- 25 Q2: 26 filings
- 25 Q3: 28 filings
- 25 Q4: 14 filings
- 26 Q1: 20 filings
- 26 Q2: 26 filings
- 26 Q3: 17 filings
- 26 Q4: 2 filings
- S-1 filed 20 Q2
- IPO 20 Q3
- Definitive agreement 22 Q3
- Completed 23 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Health Sciences Acquisitions Corporation 2 is a blank-check company seeking a business combination, with intended focus on healthcare innovation and companies developing biopharma and medical technology assets in North America or Europe.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2020-08-05
- Total Redemptions
- $16M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2023-01-25
- Merger Target
- Orchestra BioMed, Inc.
- SPAC Ticker
- HSAQ
- Merged Ticker
- OBIO
Stock Performance
OBIOTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2020-08-05 | $11.75 | |
| At Merger | 2023-01-27 | $11.50 | -2% |
| 6 Months Post-Merger | 2023-07-28 | $5.36 | -53% |
| 1 Year Post-Merger | 2024-01-26 | $7.32 | -36% |
| 2 Years Post-Merger | 2025-01-28 | $5.32 | -54% |
| Current Price | 2026-10-06 | $5.98 | -49% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Roderick Wong and Naveen Yalamanchi, RTW healthcare investors with more than 30 years of combined healthcare-investing experience; the broader team brings life-sciences, scientific, legal, operating and investment-banking expertise.